Evidence map›Paper›PMID 41040265›Full record

ArticlebioRxiv : the preprint server for biology2025

E2F1 induces a G0-G1 reentry transcriptional program without changing chromatin accessibility.

Gerrald A Lodewijk, Benjamin R Topacio, Seungho Lee, Sayaka Kozuki, Znala Williams, Clara J Han, Abolfazl Zargari, Tilini U Wijeratne, Neda Bidoki, Silvart Arabian and 8 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Gerrald A LodewijkDepartment of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA.
Benjamin R TopacioDepartment of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA.
Seungho LeeDepartment of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA.
Sayaka KozukiDepartment of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA.
Znala WilliamsDepartment of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA.
Clara J HanDepartment of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA.
Abolfazl ZargariDepartment of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA.
Tilini U WijeratneDepartment of Chemistry and Biochemistry, University of California, Santa Cruz, Santa Cruz, United States.
Neda BidokiDepartment of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA.
Silvart ArabianDepartment of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA.
Edward WuDepartment of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA.
Eric MalekosDepartment of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA.
Joscha WeissFriedrich Miescher Institute for Biomedical Research, Maulbeerstrasse 66, 4058 Basel, Switzerland.
Gerd A MüllerDepartment of Chemistry and Biochemistry, University of California, Santa Cruz, Santa Cruz, United States.
Vanessa JonssonDepartment of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA.
Nicolas H ThomäFriedrich Miescher Institute for Biomedical Research, Maulbeerstrasse 66, 4058 Basel, Switzerland.
Seth M RubinDepartment of Chemistry and Biochemistry, University of California, Santa Cruz, Santa Cruz, United States.
S Ali ShariatiDepartment of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA.

Funding

Project 3: Defining and targeting mechanisms of E2F transcription factor regulationP01CA254867 · NCI · STANFORD UNIVERSITY · PI Jan M Skotheim · 2022 to 2026
$8.9M
IRACDA at UCSC and CSUMBK12GM139185 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI FORSBERG, CAMILLA, HINCK, LINDSAY E · 2020 to 2024
$4.1M
Molecular Mechanisms of Cell Cycle Dependent Gene ExpressionR35GM145255 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI Seth Michael Rubin · 2022 to 2026
$3.0M
Molecular feedback between cell division cycle and differentiation in pluripotent stem cellsR35GM147395 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI Ali Shariati · 2022 to 2026
$1.9M
Determining feedback mechanisms between cell cycle and cell fate in pluripotent cellsR00GM126027 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI SHARIATI, ALI · 2020 to 2022
$747k
Determining feedback mechanisms between cell cycle and cell fate in pluripotent cellsK99GM126027 · NIGMS · STANFORD UNIVERSITY · PI SHARIATI, ALI · 2018 to 2019
$109k
NCI NIH HHS P01 CA254867NIGMS NIH HHS K12 GM139185NIGMS NIH HHS K99 GM126027NIGMS NIH HHS R00 GM126027NIGMS NIH HHS R35 GM145255NIGMS NIH HHS R35 GM147395
6 · The paper itself

Abstract

Quiescent cells actively repress cell-cycle genes via chromatin-based mechanisms to maintain a non-dividing state, yet remain poised to reenter upon stimulation. E2F1, a canonical activator of cell-cycle genes, is sufficient to induce reentry from quiescence, but how it overcomes chromatin-mediated repression remains unclear. Here, we show that inducible E2F1 expression triggers exit from quiescence and progression through the cycle without changes in chromatin accessibility, by harnessing regulatory elements with limited, pre-existing accessibility. Using time-resolved transcriptomics, we demonstrate that E2F1 induces an accelerated transcriptional program compared to serum. Unlike serum, which triggers broad chromatin remodeling, E2F1-induced activation occurs in a context of limited accessibility. ChIP-seq reveals that E2F1 directly binds target sites in quiescent cells to upregulate canonical genes. Biochemical reconstitution shows that E2F1 binds nucleosomes and accesses internal E2F sites within histone-wrapped DNA. These findings suggest that E2F1 can engage nucleosome-associated DNA and initiate transcription without major chromatin reorganization, redefining transcription factor-chromatin dynamics during cell fate transitions and establishing E2F1 as a potent regulator of cell-cycle reentry.

Identifiers

PMID41040265
PMCPMC12486124

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.